GENTIAN DIAGNOSTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.2 NOK | -0.51% |
|
-3.92% | -5.54% |
| 30/04 | Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 30/04 | Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024 |
Chart calendar Gentian Diagnostics
e72c030d573cce0178c23dc.9v17uESl_FZ0VeAVrqHLxK-6VWTDfO_NtE_IAmSrs2A.sZgZ_hvcjW5BPJZYm5f5lNX2HReqTZmu1QiXdifp_xS7pBrSBe3KODEtlw~912f4228d933af904c5adc8e65aaf8e4
Upcoming events on Gentian Diagnostics
Past events on Gentian Diagnostics
| 30/04/2024 12:30 pm | Q1 2024 Earnings Call |
| 30/04/2024 11:30 am | Q1 2024 Earnings Release |
| 29/04/2024 | Annual General Meeting |
| 16/03/2024 | China Association of Clinical Laboratory Practice Expo |
| 09/02/2024 01:30 pm | Q4 2023 Earnings Call |
| 09/02/2024 12:30 pm | Q4 2023 Earnings Release |
| 07/02/2024 | European Hidradenitis Suppurativa Foundation Conference |
| 26/10/2023 01:30 pm | Q3 2023 Earnings Call |
| 26/10/2023 11:30 am | Q3 2023 Earnings Release |
| 24/08/2023 01:30 pm | Q2 2023 Earnings Call |
| 24/08/2023 11:30 am | Q2 2023 Earnings Release |
| 31/05/2023 09:30 am | ABGSC Life Science Summit |
| 05/05/2023 12:30 pm | Q1 2023 Earnings Call |
| 05/05/2023 11:30 am | Q1 2023 Earnings Release |
| 04/05/2023 01:30 pm | Annual General Meeting |
| 21/03/2023 | International Symposium on Intensive Care & Emergency Medicine |
| 16/02/2023 02:30 pm | FY 2022 Earnings Call |
| 16/02/2023 12:30 pm | FY 2022 Earnings Release |
| 27/10/2022 01:30 pm | Q3 2022 Earnings Call |
| 27/10/2022 11:45 am | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 55,4 | 78,9 78,5 0.45% | 101 104 -2.64% | 112 112 0.33% | 142 142 0.33% | 174 |
|
EBITDA Million NOK | Released Forecast Spread | 0,00 | -11,2 -8,63 -29.79% | -7,60 -6,00 -26.67% | -13,0 -14,2 8.66% | 3,27 4,56 -28.24% | 14,7 |
|
EBIT Million NOK | Released Forecast Spread | 0,00 | -17,8 -14,9 -19.79% | -14,9 -14,0 -6.47% | -23,2 -24,2 3.96% | -12,8 -5,74 -122.15% | 3,63 |
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | 0,00 | -17,5 -14,0 -24.93% | -24,8 -17,0 -45.66% | -23,6 -24,3 2.62% | -10,4 -3,46 -199.13% | 7,67 |
|
Net income Million NOK | Released Forecast Spread | -39,9 | -17,5 -14,0 -24.93% | -24,8 -17,0 -45.66% | -23,6 -24,3 2.62% | -10,4 -3,46 -199.13% | 7,67 |
|
EPS NOK | Released Forecast Spread | 0,00 | -1,13 -0,91 -24.48% | -1,61 -1,10 -45.96% | -1,53 -1,57 2.71% | -0,69 -0,22 -207.35% | 0,50 |
| Announcement Date | 14/02/20 | 11/02/21 | 17/02/22 | 16/02/23 | 09/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 23,1 24,5 -5.84% | 32,9 30,0 9.48% | 25,1 24,4 2.74% | 30,9 30,5 1.19% | 33,6 29,4 14.42% |
|
EBITDA Million NOK | Released Forecast Spread | -4,18 -0,65 -547.18% | -1,24 3,88 -131.94% | -6,06 -3,13 -93.82% | -1,50 -2,73 45% | -0,52 -9,32 94.46% |
|
EBIT Million NOK | Released Forecast Spread | -6,25 -2,44 -155.97% | -3,98 2,09 -290.87% | -8,74 -5,04 -73.33% | -4,27 -5,23 18.27% | -2,88 -7,51 61.74% |
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -6,63 -3,13 -111.55% | -2,99 1,49 -300.91% | -9,38 -5,66 -65.82% | -4,63 -5,26 12.04% | -0,66 -7,56 91.31% |
|
Net income Million NOK | Released Forecast Spread | -6,63 -3,13 -111.55% | -2,99 1,49 -300.91% | -9,38 -5,66 -65.82% | -4,63 -5,26 12.04% | -0,66 -7,56 91.31% |
|
EPS NOK | Released Forecast Spread | -0,43 -0,20 -111.62% | -0,19 0,10 -296.77% | -0,61 -0,37 -66.24% | ||
| Announcement Date | 28/04/22 | 25/08/22 | 27/10/22 | 16/02/23 | 05/05/23 |
More events
Past sector events for Gentian Diagnostics
| 08/05/2024 01:35 am | MYRIAD GENETICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | CASTLE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | LANTHEUS HOLDINGS, INC.: Q1 2024 Earnings Release |
| 01/05/2024 01:35 am | 10X GENOMICS, INC.: Q1 2024 Earnings Release |
| 30/04/2024 | ASSURE TECH (HANGZHOU) CO., LTD.: Q1 2024 Earnings Release |
| 30/04/2024 | SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q1 2024 Earnings Release |
| 30/04/2024 | SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q4 2023 Earnings Release |
| 30/04/2024 | ZHEJIANG ORIENT GENE BIOTECH CO.,LTD: Q4 2023 Earnings Release |
| 30/04/2024 | CHEMCLIN DIAGNOSTICS CO., LTD.: Q4 2023 Earnings Release |
| 30/04/2024 | ASSURE TECH (HANGZHOU) CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GENT Stock
- Calendar Gentian Diagnostics